Home›Carbidopa›Carbidopa + Carbidopa Levodopa And Entacapone

Does Carbidopa Interact with Carbidopa Levodopa And Entacapone?

CDI records a major classification for Carbidopa and Carbidopa Levodopa And Entacapone. The stored summary is: May result in increased heart rates, possibly arrhythmias, and excessive changes in blood pressure. Metabolized by COMT. The mechanism involves comt metabolism inhibition by entacapone. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Carbidopa Class
Aromatic Amino Acid Decarboxylation Inhibitor
Carbidopa Levodopa And Entacapone Class
Aromatic Amino Acid
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

COMT metabolism inhibition by entacapone

What To Tell Your Doctor or Pharmacist

If you are taking Carbidopa and your doctor is considering prescribing Carbidopa Levodopa And Entacapone (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Carbidopa(Lodosyn)+💊 Carbidopa Levodopa And Entacapone(Stalevo)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Aromatic Amino Acid Decarboxylation Inhibitor
Drug B class
Aromatic Amino Acid
Source
NLP:carbidopa, levodopa and entacapone

What this means in plain English

May result in increased heart rates, possibly arrhythmias, and excessive changes in blood pressure. Metabolized by COMT.

About Carbidopa and Carbidopa Levodopa And Entacapone

Carbidopa is an Aromatic Amino Acid Decarboxylation Inhibitor, while Carbidopa Levodopa And Entacapone is an Aromatic Amino Acid. You may recognize them by the brand names Lodosyn and Stalevo.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:carbidopa, levodopa and entacapone

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Carbidopa and Carbidopa Levodopa And Entacapone against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations